Page last updated: 2024-10-29

iproniazid and Phenylketonurias

iproniazid has been researched along with Phenylketonurias in 2 studies

Phenylketonurias: A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KIRMAN, BH1
PARE, CM1
CHRISTIAENS, L1
GAUDIER, B1
BRIET, B1

Other Studies

2 other studies available for iproniazid and Phenylketonurias

ArticleYear
Amine-oxidase inhibitors as possible treatment for phenylketonuria.
    Lancet (London, England), 1961, Jan-14, Volume: 1, Issue:7168

    Topics: Amines; Iproniazid; Oxidoreductases; Phenylketonurias

1961
[PHENYLKETONURIA. APROPOS OF A FAMILIAL CASE].
    Pediatrie, 1963, Volume: 18

    Topics: Blood Chemical Analysis; Body Fluids; Diet; Diet Therapy; Electroencephalography; Genetics, Medical;

1963